P. Bertin, F. Rannou, L. Grange, Jean-Noel Dachicourt, P. Bruel, C. Emery, N. Grandfils, C. Taieb
{"title":"Annual Cost of Patients with Osteoarthritis of the Hip and Knee in France","authors":"P. Bertin, F. Rannou, L. Grange, Jean-Noel Dachicourt, P. Bruel, C. Emery, N. Grandfils, C. Taieb","doi":"10.3109/10582452.2014.937550","DOIUrl":null,"url":null,"abstract":"ABSTRACT Objectives: The economic burden of osteoarthritis [OA] has not recently been evaluated in France. This study aimed to provide a health economic update of the patient costs associated with hip or knee OA treated in the community and in medical, surgical and obstetric care [MSO] and post-acute care and rehabilitation [PAC] hospitals in France. Methods: We analyzed data from the Disease Analyzer® database of medical records collected by a representative sample of French general practitioners in 2009–2010 and from the French medical information system program for public and private hospitals in 2010. Results: In 2010, 90 946 patients were hospitalized in MSOs for hip OA [median age: 75 years] and 84 848 patients for knee OA [median age: 71 years], of whom 44% and 61%, respectively, were transferred to PACs. Up to 94.5% of patients underwent joint replacement. Hospitalization engendered annual costs of €9797 per patient with hip OA and €11 644 per patient with knee OA, that is, a total cost of €1.955 billion for patients hospitalized for hip or knee OA in 2010. A total of 18 976 community patients [mean age: 66 ± 12.7 years] with OA were followed up for 1 year in the Disease Analyzer® database. The annual costs per patient were €715 and €764 for hip and knee OA, respectively, including a cost to the healthcare system of €425 and €454, respectively, that is, an estimated €3.5 billion [€2 billion to the healthcare system] for 4.6 million patients. Conclusion: Patients with OA generate considerable healthcare costs in France.","PeriodicalId":50121,"journal":{"name":"Journal of Musculoskeletal Pain","volume":"22 1","pages":"356 - 364"},"PeriodicalIF":0.0000,"publicationDate":"2014-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/10582452.2014.937550","citationCount":"13","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Musculoskeletal Pain","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3109/10582452.2014.937550","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 13
Abstract
ABSTRACT Objectives: The economic burden of osteoarthritis [OA] has not recently been evaluated in France. This study aimed to provide a health economic update of the patient costs associated with hip or knee OA treated in the community and in medical, surgical and obstetric care [MSO] and post-acute care and rehabilitation [PAC] hospitals in France. Methods: We analyzed data from the Disease Analyzer® database of medical records collected by a representative sample of French general practitioners in 2009–2010 and from the French medical information system program for public and private hospitals in 2010. Results: In 2010, 90 946 patients were hospitalized in MSOs for hip OA [median age: 75 years] and 84 848 patients for knee OA [median age: 71 years], of whom 44% and 61%, respectively, were transferred to PACs. Up to 94.5% of patients underwent joint replacement. Hospitalization engendered annual costs of €9797 per patient with hip OA and €11 644 per patient with knee OA, that is, a total cost of €1.955 billion for patients hospitalized for hip or knee OA in 2010. A total of 18 976 community patients [mean age: 66 ± 12.7 years] with OA were followed up for 1 year in the Disease Analyzer® database. The annual costs per patient were €715 and €764 for hip and knee OA, respectively, including a cost to the healthcare system of €425 and €454, respectively, that is, an estimated €3.5 billion [€2 billion to the healthcare system] for 4.6 million patients. Conclusion: Patients with OA generate considerable healthcare costs in France.